Traditional Chinese medicine · Western herbalism
BerberineBerberis, Hydrastis, Coptis and Mahonia species (source plants)
An alkaloid from barberry, goldenseal and coptis. One IBS-D trial used 400 mg a day for 8 weeks; it also changes how the body handles several medicines.
- Botanical name
- Berberis, Hydrastis, Coptis and Mahonia species (source plants)
- Part used
- root, rhizome and stem bark of the source plants; sold as the isolated alkaloid
- Also called
- pinyin Huang lian (coptis rhizome, a berberine-rich source) (黄连); Barberry alkaloid, Berberine hydrochloride, Berberine sulfate
- Used in
- Traditional Chinese medicine, Western herbalism
- Taken for
- Loose stools and diarrhea, Cramping and pain, Antimicrobial use
- Sold as
- capsules, tablets, tincture, powder
What berberine is
Berberine is a yellow isoquinoline alkaloid, not a whole herb. It is concentrated in the roots, rhizomes and stem bark of several plants: barberry (Berberis vulgaris), goldenseal (Hydrastis canadensis), coptis or goldthread (Coptis chinensis), and Oregon grape (Mahonia aquifolium).
Supplements usually contain berberine hydrochloride at a standardized amount per capsule, which is different from taking a barberry or goldenseal root powder, where berberine is one alkaloid among several. A pharmacokinetic review puts the bioavailability of berberine at less than 1 percent because of poor solubility and absorption, so most of an oral dose stays in the gut, where it is excreted in feces (11 to 23 percent of the dose in the reviewed work), with a smaller share absorbed and metabolized by the liver.
Berberine has two identities on the page: a plant constituent in traditional medicine, and an isolated compound studied in human trials for diarrhea, irritable bowel syndrome (IBS) and blood sugar. The two bodies of evidence are kept separate below.
What the traditions use it for
Traditional Chinese medicine (about TCM)
TCM texts class coptis rhizome (huang lian), the most widely cited berberine-rich herb, as bitter and cold. In the tradition’s terms it “clears heat and dries dampness,” and the pattern it is listed for is damp-heat in the stomach and intestines, a picture that includes diarrhea, dysentery and nausea with vomiting from what the texts call stomach heat. Practitioner references add that it is not used for cold or deficient patterns and that long use without tonifying herbs is thought to harm the spleen and stomach. It is prescribed inside formulas, not alone. A pharmacology paper on berberine and newborn jaundice describes huanglian as a traditional Chinese herb whose main ingredient is berberine.
Western herbalism
Berberine-bearing plants entered Western herbalism by several routes. NCCIH records that Native Americans used goldenseal, a berberine source, for digestive disorders, wounds, and skin and eye conditions; it is now sold as a supplement for colds, diarrhea, constipation and other complaints. These are statements about how the plants were used, not findings about the isolated alkaloid.
The constituents
Berberine is a quaternary isoquinoline alkaloid. In goldenseal it sits alongside hydrastine and canadine; coptis and barberry carry berberine with related alkaloids such as palmatine. In laboratory and animal work it has antimicrobial activity, and in the 1987 cholera and E. coli trial it acted as an antisecretory agent, reducing stool volume in infected patients. Its metabolites are formed by demethylenation and then glucuronidation, sulfation and methylation. Lab findings on drug-metabolizing enzymes and the P-glycoprotein transporter are covered under interactions.
The human evidence
For IBS with diarrhea (IBS-D), the main randomized trial recruited 196 patients and randomized 132 to berberine hydrochloride 400 mg a day (given twice daily) or placebo for 8 weeks, followed by a 4-week washout. Diarrhea frequency (P = 0.032), abdominal pain frequency (P < 0.01) and urgency (P < 0.01) fell more with berberine than with placebo, and the drug was well tolerated. A meta-analysis of 19 randomized trials with 1,489 participants tested berberine added to other IBS-D treatments, not berberine alone; combinations raised the response rate (odds ratio 4.19), and the authors still called the evidence insufficient because the studies were small.
For diarrhea in general, a systematic review of 38 trials with 3,948 participants (27 of them in children, 22 of those using berberine as an enema) found higher clinical cure rates and shorter diarrhea with berberine than with control groups, with no deaths or serious adverse events. The evidence quality was moderate to low or very low. In a 1987 trial of 165 adults with diarrhea from toxin-producing E. coli or cholera, a single 400 mg dose of berberine sulfate cut stool volume, and 42 percent of the E. coli patients had stopped having diarrhea at 24 hours versus 20 percent of controls. In cholera the effect was slight, and 1,200 mg added to tetracycline did not lower stool output further.
For metabolic outcomes, which are covered here briefly, a trial of 116 people with type 2 diabetes and dyslipidemia gave 1.0 g a day for 3 months: fasting glucose fell from 7.0 to 5.6 mmol/L and HbA1c from 7.5 to 6.6 percent. An umbrella review of 11 meta-analyses found effects on glucose, insulin resistance and lipids and called for higher-quality trials. We did not find trials of berberine on constipation, reflux or bloating as primary outcomes.
| Study | Dose | What it found |
|---|---|---|
| Randomized placebo-controlled trial in IBS-D, 196 recruited, 132 randomized PMID 26400188 | 400 mg berberine hydrochloride a day, twice daily, 8 weeks | Diarrhea frequency (P = 0.032), pain frequency and urgency (both P < 0.01) reduced more than placebo |
| Meta-analysis of 38 randomized trials, 3,948 participants (27 trials in children) PMID 33149763 | Various; 22 of 27 pediatric trials used enemas | Higher clinical cure rate and shorter diarrhea than control; no serious adverse events; low-quality evidence |
| Randomized trials in adults with E. coli or cholera diarrhea, 165 patients PMID 3549923 | 400 mg berberine sulfate once | E. coli: 42% vs 20% free of diarrhea at 24 hours; cholera effect slight |
| Meta-analysis of 19 randomized trials in IBS-D, 1,489 participants (berberine plus other agents) PMID 42877511 | Various, in combination | Response rate odds ratio 4.19; authors call evidence insufficient |
| Randomized placebo-controlled trial in type 2 diabetes with dyslipidemia, 116 people PMID 18397984 | 1.0 g a day, 3 months | Fasting glucose 7.0 to 5.6 mmol/L; HbA1c 7.5% to 6.6%; mild to moderate constipation in 5 |
Doses, in trials and in practice
The IBS-D trial used 400 mg of berberine hydrochloride a day, given as two doses, for 8 weeks. The 1987 diarrhea trials used a single 400 mg dose of berberine sulfate. The diabetes trial used 1.0 g a day for 3 months. The cyclosporine study in volunteers used 0.3 g twice daily for 10 days. In traditional use the berberine arrives as the whole herb: coptis rhizome in decoctions inside a formula, or barberry and goldenseal as teas, capsules and tinctures, at amounts that depend on the herb and the practitioner, with no standard berberine content.
The amounts above are what trials and pharmacopoeias record, not a dose for you; your medicines and conditions change the answer, and a clinician or pharmacist who knows them is the person to ask.
What is known about safety
Gastrointestinal effects are the common ones. An umbrella review lists constipation and diarrhea as side effects, and the diabetes trial recorded mild to moderate constipation in 5 of the berberine group. In the diarrhea and IBS-D trials no serious adverse events were reported.
Berberine displaced bilirubin from albumin in a laboratory study, about tenfold more strongly than phenylbutazone, and raised unbound bilirubin in adult rats; the authors concluded berberine-rich herbs are best avoided in jaundiced newborns and pregnant women. NCCIH makes the same point about goldenseal, saying the berberine constituent can be harmful to newborns. Safety in pregnancy and breastfeeding has not been established by trials. Supplement content varies by product, and the reviews we read note that evidence for long-term use is limited.
Where it meets prescription medicines
Berberine inhibits the P-glycoprotein transporter in rats and increased the exposure of cyclosporine and digoxin there (digoxin AUC 169 percent of control at 100 mg/kg). In six volunteers given 0.3 g of berberine twice daily for 10 days, cyclosporine at 3 mg/kg had a 19.2 percent higher AUC (P < 0.05), while at 6 mg/kg there was no significant change. Sources also report effects on CYP3A4 and note a glucose-lowering action, so medicines for blood sugar, transplant and heart rhythm are the classes most often flagged.
Medicines the site’s own interaction rules flag with berberine
The quiz applies these rules when someone names a medicine. They come from published interaction references and are a reason to ask a pharmacist, not a diagnosis:
- cyclosporine (not combined)
- empagliflozin (not combined)
- glibenclamide (not combined)
- glimepiride (not combined)
- glipizide (not combined)
- glyburide (not combined)
- insulin (not combined)
- insulin glargine (not combined)
- insulin lispro (not combined)
- liraglutide (not combined)
- metformin (not combined)
- pioglitazone (not combined)
- rosiglitazone (not combined)
- semaglutide (not combined)
- sitagliptin (not combined)
- tacrolimus (not combined)
- acetaminophen / codeine (flagged to check)
- alprazolam (flagged to check)
- and 80 more
Catalog entries that list berberine
If you want berberine in a product rather than as a loose herb, these are the entries that carry it, with the label amounts and the reviews read.
Match it to your own case
The quiz takes about three minutes, asks what you have tried and which medicines you take, and shows the products whose trials and labels fit, with the reasons.
Take the quizHerbs that sit beside it
The questions that come up
Is berberine a herb?
No. It is a single alkaloid found in several plants, including barberry, goldenseal, coptis and Oregon grape. Supplements usually contain the purified alkaloid, which is a different thing from a root powder of one of those plants.
What did the IBS-D trial find?
In a randomized trial of 132 people with IBS-D, 400 mg of berberine hydrochloride a day for 8 weeks reduced diarrhea frequency, abdominal pain frequency and urgency more than placebo. The later meta-analysis of 19 trials tested berberine combined with other drugs, so it does not show berberine alone.
Is goldenseal the same as berberine?
Goldenseal contains berberine along with hydrastine and canadine. NCCIH notes that very little berberine may be absorbed when goldenseal is taken by mouth, so berberine trial results may not apply to goldenseal itself.
Does berberine interact with medicines?
Lab, animal and small human studies show it can raise levels of cyclosporine, a medicine cleared in part by CYP3A4 and P-glycoprotein. It also lowers blood glucose, which matters for people on diabetes medicines. The advice in the sources is to check with a prescriber or pharmacist first.
Why is it flagged around newborns and pregnancy?
A laboratory study found berberine pushes bilirubin off albumin, the protein that carries it in blood, which is a concern in jaundiced newborns. Trials have not established safety in pregnancy or breastfeeding, and NCCIH advises against goldenseal in both.
Sources
- Chen C et al., "A Randomized Clinical Trial of Berberine Hydrochloride in Patients with Diarrhea-Predominant Irritable Bowel Syndrome", Phytother Res 2015;29:1822-7 pubmed.ncbi.nlm.nih.gov/26400188
- Yu M et al., "Berberine for diarrhea in children and adults: a systematic review and meta-analysis", Ther Adv Gastroenterol 2020;13:1756284820961299 pubmed.ncbi.nlm.nih.gov/33149763
- Rabbani GH et al., "Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxigenic Escherichia coli and Vibrio cholerae", J Infect Dis 1987;155:979-84 pubmed.ncbi.nlm.nih.gov/3549923
- Liu N et al., "A meta-analysis of berberine combined with brain-gut axis-targeted agents for diarrhoea-predominant irritable bowel syndrome", Front Pharmacol 2026;17:1795170 pubmed.ncbi.nlm.nih.gov/42877511
- Zhang Y et al., "Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine", J Clin Endocrinol Metab 2008;93:2559-65 pubmed.ncbi.nlm.nih.gov/18397984
- Li Z et al., "Berberine and health outcomes: An umbrella review", Phytother Res 2023;37:2051-66 pubmed.ncbi.nlm.nih.gov/36999891
- Khoshandam A et al., "Pharmacokinetic of berberine, the main constituent of Berberis vulgaris L.: A comprehensive review", Phytother Res 2022;36:4063-79 pubmed.ncbi.nlm.nih.gov/36221815
- Xin HW et al., "The effects of berberine on the pharmacokinetics of cyclosporin A in healthy volunteers", Methods Find Exp Clin Pharmacol 2006;28:25-9 pubmed.ncbi.nlm.nih.gov/16541194
- Qiu W et al., "Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp", Phytother Res 2009;23:1553-8 pubmed.ncbi.nlm.nih.gov/19370549
- Chan E, "Displacement of bilirubin from albumin by berberine", Biol Neonate 1993;63:201-8 pubmed.ncbi.nlm.nih.gov/8513024
- NCCIH, "Goldenseal" www.nccih.nih.gov/health/goldenseal
- Huang Lian (Coptis rhizome), Chinese herbal medicine materia medica entry (practitioner reference) www.attiliodalberto.com/chinese-herbal-medicine/herbs/huang-lian.php